Immucell Corp /De/
Diagnostics company · Portland, Maine, United States · Nasdaq: ICCC
Immucell Corp /De/ is a diagnostics company headquartered in Portland, Maine, United States. Its shares trade on Nasdaq under the ticker ICCC. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2016.
Immucell Corp /De/ at a glance
What does Immucell Corp /De/ do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $3.5 million sold (2016).
Frequently asked questions about Immucell Corp /De/
Where is Immucell Corp /De/ headquartered?
Immucell Corp /De/ is headquartered in Portland, Maine, United States.
What does Immucell Corp /De/ do?
Immucell Corp /De/ is a diagnostics company. Its SEC industry classification is In Vitro & In Vivo Diagnostic Substances.
Is Immucell Corp /De/ a public company?
Yes. Immucell Corp /De/ trades on Nasdaq under the ticker ICCC.
Similar companies
- Hemex Health IncPortland, Oregon, United States
- Rewire Neuroscience LLCPortland, Oregon, United States
- Achieve Life Sciences, Inc.Seattle, Washington, United States
- Celldex Therapeutics, Inc.Hampton, New Jersey, United States
- Navidea Biopharmaceuticals, Inc.Dublin, Ohio, United States
- Eyenuk, Inc.Woodland Hills, California, United States
- Visby Medical, Inc.San Jose, California, United States
- Lucira Health, Inc.Emeryville, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences